BioClinica, a specialty clinical trials services and technology provider, has named David Peters executive vice president and chief financial officer. He will be joining BioClinica on June 8, 2015.

Mr. Peters brings more than 25 years of financial and accounting experience with a focus in pharmaceutical services.

“David has extensive and deep knowledge in all areas of finance, accounting and business operations and understands the specifics of our high growth and diverse business segments in both private and public markets, making him well-suited for the position,” said BioClinica chief executive officer, John Hubbard.

Mr. Peters has directed all facets of accounting, financial functions and strategy in global businesses and has successfully negotiated more than 20 strategic partnership agreements. He was most recently chief financial officer at WCCT Global where he developed the strategic plan, successfully positioning the contract research organization for growth and investment. 

Mr. Peters replaces executive vice president and chief financial officer Ted Kaminer, who is retiring after 12 years with the company.